OKYO Pharma OKYO
NASDAQ OKYO
$1.38 +0.06 (+4.53%)
As of: Oct 2, 2026 · 11:03 AM EDT

OKYO Pharma (OKYO) Net Equity Issued and Repurchased (2025 - 2026)

Updated

OKYO Pharma (OKYO) recorded Net Equity Issued and Repurchased of $23.32 million in the quarter ended Mar 31, 2026.

Analysis

OKYO Pharma (OKYO) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

For the year ended Mar 31, 2026, OKYO Pharma reported Net Equity Issued and Repurchased of $25.02 million.

  • Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of 336.1% (years ended Mar 2021 to Mar 2026).
  • Across earlier years, Net Equity Issued and Repurchased came in at $1.71 million in the year ended Mar 31, 2025, $6.21 million in the year ended Dec 31, 2024 (-15.2%), $7.32 million in the year ended Dec 31, 2023 and $2.15 million in the year ended Mar 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 OKYO Pharma 867.87 Mn 867.87 Mn - 23.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 23.32 Mn
Dec 31, 2025 -2.61 Mn
API Access

OKYO Pharma Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=OKYO&period=max&api_key=YOUR_API_KEY